{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:59:09Z","timestamp":1791237549587,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["seminperinat.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1053\/j.semperi.2014.03.006","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T11:25:00Z","timestamp":1400153100000},"page":"159-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["First trimester prediction of ischemic placental disease"],"prefix":"10.1053","volume":"38","author":[{"given":"Anthony M.","family":"Vintzileos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cande V.","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2014.03.006_bib1","unstructured":"Centers for Disease Control and Prevention. Available at \u3008ftp:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/Dataset_Documentation\/DVS\/natality\/UserGuide2010.pdf\u3009; Accessed 31.12.13."},{"issue":"5 Pt 1","key":"10.1053\/j.semperi.2014.03.006_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/01.AOG.0000158124.96300.c7","article-title":"Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000","volume":"105","author":"Ananth","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0002-9378(98)70439-9","article-title":"The preterm prediction study: risk factors for indicated preterm births. Maternal\u2013Fetal Medicine Units Network of the National Institute of Child Health and Human Development","volume":"178","author":"Meis","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0029-7844(94)00455-M","article-title":"The origin and outcome of preterm twin pregnancies","volume":"85","author":"Gardner","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ajog.2006.05.021","article-title":"Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth","volume":"195","author":"Ananth","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-0528.1980.tb04419.x","article-title":"Fetal growth retardation and preeclampsia","volume":"87","author":"Long","year":"1980","journal-title":"BJOG"},{"key":"10.1053\/j.semperi.2014.03.006_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajog.2005.07.049","article-title":"Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia","volume":"195","author":"Ness","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.AOG.0000266983.77458.71","article-title":"Recurrence of ischemic placental disease","volume":"110","author":"Ananth","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0143-4004(80)80012-9","article-title":"Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy","volume":"1","author":"Pijnenborg","year":"1980","journal-title":"Placenta"},{"key":"10.1053\/j.semperi.2014.03.006_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1053\/j.semperi.2014.03.006_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1469-0705.1995.05050328.x","article-title":"Early uterine artery Doppler velocimetry and the outcome of pregnancy in women aged 35 years and older","volume":"5","author":"van den Elzen","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1469-0705.1997.09020094.x","article-title":"Transvaginal uterine and umbilical artery Doppler examination of 12-16 weeks and the subsequent development of pre-eclampsia and intrauterine growth retardation","volume":"2","author":"Harrington","year":"1997","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.0960-7692.2001.00594.x","article-title":"Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11\u201314 weeks of gestation","volume":"18","author":"Martin","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/uog.2686","article-title":"A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound","volume":"27","author":"Nicolaides","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/uog.5157","article-title":"Uterine artery Doppler at 11 + 0 to + 13 + 6 weeks in the prediction of pre-eclampsia","volume":"30","author":"Plasencia","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14767050701500349","article-title":"Maternal serum soluble adhesion molecule levels at 11+0+13+6 weeks and subsequent development of pre-eclampsia","volume":"20","author":"Parra-Cordero","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2014.03.006_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/uog.6212","article-title":"Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia","volume":"32","author":"Spencer","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.5165","article-title":"First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses","volume":"31","author":"Spencer","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/uog.5402","article-title":"Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia","volume":"32","author":"Plasencia","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/uog.6280","article-title":"First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia","volume":"33","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet Gyencol"},{"key":"10.1053\/j.semperi.2014.03.006_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"key":"10.1053\/j.semperi.2014.03.006_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/uog.6275","article-title":"First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia","volume":"33","author":"Leal","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pd.2279","article-title":"Maternal plasma inhibin A at 11\u201313 weeks of gestation in hypertensive disorders of pregnancy","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.006_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/pd.2307","article-title":"Maternal serum angiopoietin-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.006_bib28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/pd.2311","article-title":"Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.006_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000235878","article-title":"Maternal serum activin A at 11\u201313 weeks of gestation in hypertensive disorders of pregnancy","volume":"25","author":"Akolekar","year":"2009","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000235880","article-title":"First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-A in preeclampsia and chromosomal defects","volume":"25","author":"Staboulidou","year":"2009","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pd.2433","article-title":"Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia","volume":"30","author":"Akolekar","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.006_bib32","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/pd.2566","article-title":"Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia","volume":"30","author":"Ashoor","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.006_bib33","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/pd.2555","article-title":"Maternal serum insulin-like growth factor-I at 11\u201313 weeks in preeclampsia","volume":"30","author":"Sifakis","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.006_bib34","first-page":"1","article-title":"Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11\u201313 weeks","volume":"11","author":"Karagiannis","year":"2010","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pd.2682","article-title":"Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11\u201313 weeks in pre-eclampsia","volume":"31","author":"Sifakis","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.006_bib36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000322402","article-title":"Maternal serum adiponectin at 11-13 weeks of gestation in preeclampsia","volume":"29","author":"Nanda","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/10641955.2010.486461","article-title":"Maternal serum human placental growth hormone (hPGH) at 11 to 13 weeks of gestation in preeclampsia","volume":"30","author":"Sifakis","year":"2011","journal-title":"Hypertens Pregnancy"},{"key":"10.1053\/j.semperi.2014.03.006_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000324318","article-title":"Placental volume at 11-13 weeks\u2019 gestation in the prediction of birth weight percentile","volume":"30","author":"Plasencia","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000333810","article-title":"Maternal serum vitamin D at 11\u201313 weeks in pregnancies delivering small for gestational age neonates","volume":"31","author":"Ertl","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/jhh.2011.16","article-title":"Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11\u201313 weeks in preeclampsia","volume":"26","author":"Sifakis","year":"2012","journal-title":"J Hum Hypertens"},{"key":"10.1053\/j.semperi.2014.03.006_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000338470","article-title":"A competing risks model in early screening for preeclampsia","volume":"32","author":"Wright","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risk model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/jhh.2012.10","article-title":"Maternal serum visfatin at 11\u201313 weeks\u2019 gestation in preeclampsia","volume":"27","author":"Ferreira","year":"2013","journal-title":"J Hum Hypertens"},{"key":"10.1053\/j.semperi.2014.03.006_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000341712","article-title":"Combined screening for preeclampsia and small for gestational age at 11\u201313 weeks","volume":"33","author":"Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.006_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/uog.3881","article-title":"Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks\u2019 gestation","volume":"29","author":"Pilalis","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/uog.11137","article-title":"Comparison of two different sites of measurement for transabdominal uterine artery Doppler velocimetry at 11\u201313 weeks","volume":"40","author":"Lefebvre","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.006_bib47","first-page":"1122","article-title":"American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy (Collaborators 22)","volume":"122","year":"2013","journal-title":"Obstet Gynecol"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000514000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000514000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T12:57:26Z","timestamp":1597841846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000514000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0146000514000160"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2014.03.006","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First trimester prediction of ischemic placental disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2014.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}